Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 37 | 83 | 143 | 8 | 0 |
| Gross Profit | 37 | 83 | 143 | 8 | N/A |
| Operating Expenses | 50,476 | 48,566 | 46,598 | 43,288 | 41,337 |
| Operating Income | -50,439 | -48,483 | -46,455 | -43,280 | -41,337 |
| Other Income | 5,182 | 5,369 | 6,212 | 3,840 | 3,832 |
| Pre-tax Income | -45,257 | -43,114 | -40,243 | -39,440 | -37,505 |
| Net Income Continuous | -45,257 | -43,114 | -40,243 | -39,440 | -37,505 |
| Net Income | $-45,257 | $-43,114 | $-40,243 | $-39,440 | $-37,505 |
| EPS Basic Total Ops | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 |
| EPS Basic Continuous Ops | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 |
| EPS Diluted Total Ops | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 |
| EPS Diluted Continuous Ops | -1.25 | -1.21 | -1.34 | -1.33 | -1.27 |
| EPS Diluted Before Non-Recurring Items | -1.25 | -1.21 | -1.34 | N/A | N/A |
| EBITDA(a) | $-50,133 | $-48,206 | $-46,208 | $-43,070 | $-41,146 |